1. Home
  2. IMCR vs ACCV Comparison

IMCR vs ACCV Comparison

Compare IMCR & ACCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

N/A

Current Price

$26.33

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Accelevation Holdings Corp. Class A Ordinary Shares

ACCV

Accelevation Holdings Corp. Class A Ordinary Shares

N/A

Current Price

$9.59

Market Cap

1.6B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
IMCR
ACCV
Founded
2008
2017
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2016
2026

Fundamental Metrics

Financial Performance
Metric
IMCR
ACCV
Price
$26.33
$9.59
Analyst Decision
Buy
Buy
Analyst Count
12
8
Target Price
★ $59.30
$19.00
AVG Volume (30 Days)
414.0K
★ 1.5M
Earning Date
11-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 30.39
N/A
EPS
N/A
★ N/A
Revenue
★ $249,428,000.00
N/A
Revenue This Year
$9.28
$103.23
Revenue Next Year
$9.91
$86.24
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 43.05
N/A
52 Week Low
$26.53
$9.54
52 Week High
$40.71
$17.92

Technical Indicators

Market Signals
Indicator
IMCR
ACCV
Relative Strength Index (RSI) 32.57 36.09
Support Level N/A $9.54
Resistance Level $31.75 $15.65
Average True Range (ATR) 1.46 1.84
MACD -0.46 -0.07
Stochastic Oscillator 9.12 12.79

Price Performance

Historical Comparison
IMCR
ACCV

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About ACCV Accelevation Holdings Corp. Class A Ordinary Shares

Accelevation Holdings Corp is a vertically integrated infrastructure platform that designs, manufactures and installs power distribution and white space infrastructure products for mission-critical environments. Its offerings comprise Infrastructure Solutions and Power Products, which can be sold separately or combined into integrated systems. Infrastructure Solutions include the SkyBridge modular platform, TechFrame steel structures and conveyance, thermal management products, and installation and maintenance services. Power Products include remote power panels, branch circuit whips, power distribution units, monitoring systems, and upstream distribution products. It derives substantially all of its revenue from offerings sold into the data center industry.

Share on Social Networks: